Literature DB >> 19562904

Retrospective multicentre study of methicillin-resistant Staphylococcus aureus infections in 115 horses.

M E C Anderson1, S L Lefebvre, S C Rankin, H Aceto, P S Morley, J P Caron, R D Welsh, T C Holbrook, B Moore, D R Taylor, J S Weese.   

Abstract

REASONS FOR PERFORMING STUDY: Methicillin-resistant Staphylococcus aureus (MRSA) is an emerging veterinary and zoonotic pathogen, associated with increasing reports of disease in horses.
OBJECTIVES: To provide an overview of the characteristics of clinical MRSA infections in horses.
METHODS: A retrospective case study was performed on 115 horses admitted to 6 participating veterinary teaching hospitals in Canada and the United States between 2000 and 2006, and diagnosed with clinical MRSA infection. Descriptive statistics, univariate and multivariable analyses for community- (CA) vs. hospital-associated (HA) MRSA infections, and survival vs. nonsurvival at discharge were performed.
RESULTS: The age range of MRSA-infected horses was zero (born in hospital) to 31 years. HA (58/114, 50.9%) and CA infections (56/114, 49.1%) were equally common. Infection of surgical incisions was most frequently reported (44/115, 38.0%). Overall 93/111 (83.8%) cases survived to discharge. Previous hospitalisation and treatment with gentamicin were associated significantly with CA-MRSA, whereas infected incision sites were associated significantly with HA-MRSA. Factors significantly associated with nonsurvival included i.v. catheterisation, CA-MRSA infection and dissemination of infection to other body sites.
CONCLUSIONS: Equine MRSA infections have a broad range of clinical presentations, appear to be primarily opportunistic and the overall prognosis for survival to discharge is good. POTENTIAL RELEVANCE: These results should help direct future research with regard to investigation of risk factors for equine MRSA infection in community and hospital populations.

Entities:  

Mesh:

Year:  2009        PMID: 19562904     DOI: 10.2746/042516408x345134

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  7 in total

1.  Optimization of a Staphylococcus aureus adhesion assay for equine corneocytes.

Authors:  Gregory C Griffeth; Nancy Callori; Shelley C Rankin; Raymond C Boston; Daniel O Morris
Journal:  Vet Dermatol       Date:  2011-10-13       Impact factor: 1.589

2.  A retrospective study on methicillin-resistant Staphylococcus spp. isolated from horses admitted to a Canadian veterinary teaching hospital between 2008 and 2018.

Authors:  Marine Roudaud; Marion Allano; Julie-Hélène Fairbrother; Frédéric Sauvé
Journal:  Can Vet J       Date:  2020-11       Impact factor: 1.008

3.  The first nosocomial outbreak of methicillin-resistant Staphylococcus aureus in horses in Sweden.

Authors:  Karin Bergström; Anna Aspan; Annica Landén; Christopher Johnston; Ulrika Grönlund-Andersson
Journal:  Acta Vet Scand       Date:  2012-02-08       Impact factor: 1.695

4.  Infection prevention and control interventions in the first outbreak of methicillin-resistant Staphylococcus aureus infections in an equine hospital in Sweden.

Authors:  Karin Bergström; Görel Nyman; Stefan Widgren; Christopher Johnston; Ulrika Grönlund-Andersson; Ulrika Ransjö
Journal:  Acta Vet Scand       Date:  2012-03-08       Impact factor: 1.695

5.  Prevalence of Methicillin-Resistant Staphylococcus aureus from Equine Nasopharyngeal and Guttural Pouch Wash Samples.

Authors:  A G Boyle; S C Rankin; L A Duffee; D Morris
Journal:  J Vet Intern Med       Date:  2017-06-29       Impact factor: 3.333

6.  Methicillin-resistant and -susceptible Staphylococcus aureus infections in dogs.

Authors:  Meredith C Faires; Michelle Traverse; Kathy C Tater; David L Pearl; J Scott Weese
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

Review 7.  Infection control and biosecurity in equine disease control.

Authors:  J S Weese
Journal:  Equine Vet J       Date:  2014-06-20       Impact factor: 2.888

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.